Acute Leukemias: FAQ
Developments in Acute Leukemias: Expert Answers to Clinician Questions

Released: October 02, 2020

Expiration: October 01, 2021

David Marks
David Marks, MD, PhD

Activity

Progress
1
Course Completed

In this episode, David Marks, MD, PhD, and Stéphane de Botton, MD, answer questions from clinicians on management pearls for patients with acute leukemias. Topics include:

  • MRD in the management of ALL
  • Therapy choice for older patients with AML
  • Optimal use of inotuzumab ozogamicin and blinatumomab for ALL
  • Use of CAR T-cell therapy for acute leukemias

Content based on an online CME program supported by an educational grant from Pfizer Inc.

Link to full program: https://www.clinicaloptions.com/oncology/programs/acute-leuk